Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision identifier was updated to v3.6.4, signaling a platform or content release update. This update does not modify study details, eligibility criteria, or displayed results.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a new publication entry for Upadacitinib efficacy in atopic dermatitis (head and neck region). Revisions indicate the current version is v3.6.3 and the older May 24, 2026 online-ahead-of-print citation (v3.6.0) was removed.SummaryDifference0.0%

- Check36 days agoChange DetectedFollowing the interim analysis, significant noncompliance was identified at a clinical site, and all data from that site (including data from 10 adolescent participants) has been excluded from the final analysis of the outcome measures as appropriate. The update also adds specific site locations (e.g., Sofia, Bulgaria; Kota Kinabalu, Sabah, Malaysia) and AbbVie’s data-sharing disclosures and related links.SummaryDifference0.5%

- Check44 days agoChange DetectedThe study is now listed as No longer looking for participants, indicating that recruitment has closed and enrollment is no longer possible. The page also adds navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows an updated Revision: v3.6.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe revision label changed from v3.5.4 to v3.5.5, indicating a new version of the page. This reflects an update to the document, without detailing what changed.SummaryDifference0.0%

- Check58 days agoChange DetectedA new publication citation has been added to the Publications section of the study page. The entry cites Eyerich et al. on Upadacitinib efficacy in atopic dermatitis of the head and neck region (online ahead of print, 2026).SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.